Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Rev. argent. radiol ; 79(1): 40-46, mar. 2015. ilus, tab
Article in Spanish | LILACS | ID: lil-750608

ABSTRACT

La osteonecrosis del maxilar inferior secundaria a la administración de bifosfonatos es una patología infrecuente. Se produce en los pacientes medicados con esta droga, ya sea por vía oral o endovenosa, que luego de realizarse un procedimiento odontológico presentan necrosis ósea en la mandíbula. Desde el primer reporte en el año 2003, se evidenció un crecimiento exponencial de esta patología. Presentamos dos casos clínicos de osteonecrosis del maxilar inferior por la administración de bifosfonatos, con el objetivo de difundir y crear conciencia entre los profesionales de la salud, considerando que no existe un tratamiento efectivo para esta entidad.


The osteonecrosis of the jaw originated by the biphosphonate administration is an infrequent pathology in patients under treatment with biophosphonates given orally or through parenteral administration after some odontological treatment. These patients manifested osteonecrosis of the jaw. Since the first case of osteonecrosis of the maxilar bone was reported in 2003, the number of patients with osteonecrosis of the jaw who have been treated with these drugs has increased notoriously. We report 2 clinical cases of patients with osteonecrosis of the jaw treated with bifosfonatos, in order to make this pathology known among the health professionals and raise awareness considering that there is no effective treatment.


Subject(s)
Humans , Female , Adult , Aged , Osteonecrosis , Bisphosphonate-Associated Osteonecrosis of the Jaw , Pain , Diphosphonates , Diphosphonates/adverse effects , Mandible
SELECTION OF CITATIONS
SEARCH DETAIL